Marine carotenoids and cardiovascular risk markers - PubMed (original) (raw)

Review

Marine carotenoids and cardiovascular risk markers

Graziano Riccioni et al. Mar Drugs. 2011.

Abstract

Marine carotenoids are important bioactive compounds with physiological activities related to prevention of degenerative diseases found principally in plants, with potential antioxidant biological properties deriving from their chemical structure and interaction with biological membranes. They are substances with very special and remarkable properties that no other groups of substances possess and that form the basis of their many, varied functions and actions in all kinds of living organisms. The potential beneficial effects of marine carotenoids have been studied particularly in astaxanthin and fucoxanthin as they are the major marine carotenoids. Both these two carotenoids show strong antioxidant activity attributed to quenching singlet oxygen and scavenging free radicals. The potential role of these carotenoids as dietary anti-oxidants has been suggested to be one of the main mechanisms for their preventive effects against cancer and inflammatory diseases. The aim of this short review is to examine the published studies concerning the use of the two marine carotenoids, astaxanthin and fucoxanthin, in the prevention of cardiovascular diseases.

Keywords: astaxanthin; atherosclerosis; cardiovascular disease; free radicals; fucoxantin; marine carotenoids; oxidized LDL.

PubMed Disclaimer

Cited by

Astaxanthin in cardiovascular health and disease.
Fassett RG, Coombes JS. Fassett RG, et al. Molecules. 2012 Feb 20;17(2):2030-48. doi: 10.3390/molecules17022030. Molecules. 2012. PMID: 22349894 Free PMC article. Review.
Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.
Lipshultz SE, Cochran TR, Briston DA, Brown SR, Sambatakos PJ, Miller TL, Carrillo AA, Corcia L, Sanchez JE, Diamond MB, Freundlich M, Harake D, Gayle T, Harmon WG, Rusconi PG, Sandhu SK, Wilkinson JD. Lipshultz SE, et al. Future Cardiol. 2013 Nov;9(6):817-48. doi: 10.2217/fca.13.66. Future Cardiol. 2013. PMID: 24180540 Free PMC article. Review.
Marine bioactives: pharmacological properties and potential applications against inflammatory diseases.
D'Orazio N, Gammone MA, Gemello E, De Girolamo M, Cusenza S, Riccioni G. D'Orazio N, et al. Mar Drugs. 2012 Apr;10(4):812-833. doi: 10.3390/md10040812. Epub 2012 Apr 5. Mar Drugs. 2012. PMID: 22690145 Free PMC article. Review.
Carotenoids: potential allies of cardiovascular health?
Gammone MA, Riccioni G, D'Orazio N. Gammone MA, et al. Food Nutr Res. 2015 Feb 6;59:26762. doi: 10.3402/fnr.v59.26762. eCollection 2015. Food Nutr Res. 2015. PMID: 25660385 Free PMC article.
Carotenoids from Marine Sources as a New Approach in Neuroplasticity Enhancement.
Pietrasik S, Cichon N, Bijak M, Gorniak L, Saluk-Bijak J. Pietrasik S, et al. Int J Mol Sci. 2022 Feb 11;23(4):1990. doi: 10.3390/ijms23041990. Int J Mol Sci. 2022. PMID: 35216103 Free PMC article. Review.

References

1. World Health Organization. Diet, Nutrition, and the Prevention of Chronic Disease. WHO; Geneva, Switzerland: 2003. (WHO Technical Report Series 916). - PubMed
1. Neaton J, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and difference by age for 316,099 white man. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med. 1992;152:56–64. - PubMed
1. Riccioni G. Carotenoids and cardiovascular disease. Curr. Atheroscler. Rep. 2009;11:434–439. - PubMed
1. Riccioni G, D’Orazio N, Speranza L, Di Ilio E, Glade M, Bucciarelli V, Scotti L, Martini F, Pennelli A, Bucciarelli T. Carotenoids and asymptomatic carotid atherosclerosis. J. Biol. Regul. Homeost. Agents. 2010;24:447–452. - PubMed
1. Gori T, Nzel TM. Oxidative stress and endothelial dysfunction: Therapeutic implications. Ann. Med. 2011;43:259–272. - PubMed

Marine carotenoids and cardiovascular risk markers - PubMed (original) (raw)